2-Chloro-N-(oxan-3-yl)pyrimidin-4-amine

Catalog No. :
ACINDL461
CAS No. :
1342391-78-9
Molecular Formula :
C9H12ClN3O
Molecular Weight :
213.67

IUPAC Name:2-chloro-N-(tetrahydro-2H-pyran-3-yl)pyrimidin-4-amine

2-Chloro-N-(oxan-3-yl)pyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$268.00Login to see priceInquiryInquiry
100mg95%$392.00Login to see priceInquiryInquiry
250mg95%$549.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-(oxan-3-yl)pyrimidin-4-amine
IUPAC Name2-chloro-N-(tetrahydro-2H-pyran-3-yl)pyrimidin-4-amine
MDL No.MFCD18339407
Molecular FormulaC9H12ClN3O
Molecular Weight213.67
SMILESClC1=NC=CC(NC2COCCC2)=N1
InChI KeySMEWBGPILUISCA-UHFFFAOYSA-N
Synonym2-chloro-N-(oxan-3-yl)pyrimidin-4-amine;4-Pyrimidinamine, 2-chloro-N-(tetrahydro-2H-pyran-3-yl)-;2-Chloro-N-(tetrahydro-2H-pyran-3-yl)-4-pyrimidinamine
CAS No.1342391-78-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACINDL461 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPIQF960 route compound structure diagram
    ACPIQF9607461-50-9 In Stock
  2. Plus
  3. ACRXYV328 route compound structure diagram
    ACRXYV32823462-75-1 In Stock
  4. Then
  5. ACINDL461 route product structure diagram
    ACINDL4611342391-78-9
Inquiry

2. ACINDL461 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJDIB261 route compound structure diagram
    ACJDIB261885702-34-1 In Stock
  2. Plus
  3. ACISTJ371 route compound structure diagram
    ACISTJ371120811-32-7 In Stock
  4. Then
  5. ACINDL461 route product structure diagram
    ACINDL4611342391-78-9
Inquiry

Comments (0)